Posts

Showing posts from July, 2025

Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association

Image
i have congestive heart failure :: Article Creator Treatments Changing The Outlook For Heart Failure Patients How new medications and devices are transforming care for 6 million Americans living with this challenging condition When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying groceries become exhausting challenges. This is the reality of congestive heart failure, a condition affecting approximately 6 million Americans, with 550,000 new cases diagnosed annually. Despite its ominous name, heart failure does not mean the heart has stopped working. Rather, it indicates the heart cannot pump sufficient blood to meet the body's needs. While once considered a terminal diagnosis, significant advances in understanding, prevention, and treatment have transformed the prognosis for many patients. Unders...

Sensors for detecting pulmonary diseases from exhaled breath - ERS

Image
pah janssen :: Article Creator Janssen Submits New Drug Application (NDA) To U.S. FDA For UPTRAVI ... SOUTH SAN FRANCISCO, Calif., Sept. 30, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for UPTRAVI® (selexipag) as an injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults with WHO functional class (FC) II–III, who are currently prescribed oral UPTRAVI but are temporarily unable to take oral therapy. In patients with PAH, interruptions in treatment should be avoided due to the progressive nature of the disease.1  UPTRAVI is a selective, prostacyclin IP receptor agonist. Oral UPTRAVI was approved by the FDA in 2015 for the treatment of PAH to delay disease progression and reduce the risk of hospitalization.2 "Even relatively short-term...

Pulmonary sarcoidosis: A comprehensive review: Past to present

Image
etiology of pulmonary tuberculosis :: Article Creator

FDA Tracker: 2024 Ends With Lilly’s Landmark GLP-1 Sleep Apnea Approval

Image
causes of resistant hypertension :: Article Creator My Patient Had High BP But No Cholesterol Or Obesity: What Was Causing It? Access Denied You don't have permission to access "http://indianexpress.Com/article/health-wellness/patient-high-bp-no-cholesterol-obesity-cause-10160314/" on this server. Reference #18.1085d817.1753938505.1db5f793 https://errors.Edgesuite.Net/18.1085d817.1753938505.1db5f793 Resistant Hypertension: Why Won't My BP Go Down? - Healio September 19, 2023 4 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . ...

Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature

Image
primary lung disease :: Article Creator Idrevadiloride In Hypertonic Saline Improves Lung Function In People ... Primary ciliary dyskenisia (PCD) is a rare genetic disease that causes the tiny hair-like filtration structures in the respiratory tract to stop working. As a result, the lungs accumulate thick mucus and become more susceptible to inflammation and recurring infections, both of which can result in long-term lung damage. Thomas W. Ferkol, Jr, MD, a pediatric pulmonologist at UNC Health and chief of pulmonology in the UNC Department of Pediatrics, and researchers at Parion Sciences Inc. Recently led a phase 2 study of idrevloride in hypertonic saline in people with primary ciliary dyskinesia (PCD). Their results, which were published in The Lancet Respiratory Medicine, demonstrate that idrevloride in hypertonic saline is safe and associated with a significant improvement in lung function over a 28-day period in individuals with prima...

Pulmonary Hypertension in Infants, Children, and Young Adults

Image
end stage lung disease :: Article Creator Increased GERD Risk In End-Stage Lung Disease Without Esophageal ... This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data. Lung Transplantation: A Treatment Option In End-stage Lung Disease In the past five years, the number of lung transplantations carried out has increased by about 20%. In the end stage of various lung diseases, transplantation is the last remaining option for treatment, and it can both prolong life and improve its quality. Marc Hartert and colleagues have studied how patients do after a lung transplant, and their review appears in the current edition of the Deutsches Ärzteblatt International. What they found is that deaths in the 90 days after an operation for...

Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era

Image
prominent pulmonary artery meaning :: Article Creator

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Image
non cardiogenic pulmonary edema causes :: Article Creator What Causes Pulmonary Edema, Or Fluid In The Lungs? The Seychelles News Agency reports that an autopsy found that two vacationing American sisters  died from acute pulmonary edema, or fluid in their lungs. According to the Mayo Clinic's website, pulmonary edema is usually cardiogenic — that is, related to a weakness or malfunction of the heart. Noncardiogenic causes can include: Pneumonia or other infection High altitude Reaction to drugs Inhalation of a toxin, smoke or water Brain injury Trauma to the lung or chest wall Originally Published: September 30, 2016 at 11:55 AM PDT Pulmonary Edema: Types, Causes, Symptoms, Treatment, And Diagnosis - WebMD Pulmonary edema is a buildup of fluid in your lungs. That can make it hard for you to breathe. When you take a breath, your lungs should fill with air. If you have pulmonary edema, they fill with fluid instead...